These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20217638)

  • 1. A new digitized method of the compulsive gnawing test revealed dopaminergic activity of salvinorin A in vivo.
    Phipps SM; Butterweck V
    Planta Med; 2010 Sep; 76(13):1405-10. PubMed ID: 20217638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents.
    Braida D; Capurro V; Zani A; Rubino T; Viganò D; Parolaro D; Sala M
    Br J Pharmacol; 2009 Jul; 157(5):844-53. PubMed ID: 19422370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of salvinorin A on locomotor sensitization to D2/D3 dopamine agonist quinpirole.
    Beerepoot P; Lam V; Luu A; Tsoi B; Siebert D; Szechtman H
    Neurosci Lett; 2008 Dec; 446(2-3):101-4. PubMed ID: 18824069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors.
    Zhang Y; Butelman ER; Schlussman SD; Ho A; Kreek MJ
    Psychopharmacology (Berl); 2005 May; 179(3):551-8. PubMed ID: 15682306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of kappa-opioid and endocannabinoid system on Salvinorin A-induced reward.
    Braida D; Limonta V; Capurro V; Fadda P; Rubino T; Mascia P; Zani A; Gori E; Fratta W; Parolaro D; Sala M
    Biol Psychiatry; 2008 Feb; 63(3):286-92. PubMed ID: 17920565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa-opioid and CB1-cannabinoid receptor involvement.
    Braida D; Limonta V; Pegorini S; Zani A; Guerini-Rocco C; Gori E; Sala M
    Psychopharmacology (Berl); 2007 Mar; 190(4):441-8. PubMed ID: 17219220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues.
    Riley AP; Groer CE; Young D; Ewald AW; Kivell BM; Prisinzano TE
    J Med Chem; 2014 Dec; 57(24):10464-75. PubMed ID: 25426797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A reduce inflammation-induced hypermotility in mice.
    Capasso R; Borrelli F; Zjawiony J; Kutrzeba L; Aviello G; Sarnelli G; Capasso F; Izzo AA
    Neurogastroenterol Motil; 2008 Feb; 20(2):142-8. PubMed ID: 17931335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors.
    Capasso R; Borrelli F; Cascio MG; Aviello G; Huben K; Zjawiony JK; Marini P; Romano B; Di Marzo V; Capasso F; Izzo AA
    Br J Pharmacol; 2008 Nov; 155(5):681-9. PubMed ID: 18622408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinociceptive and hypothermic effects of Salvinorin A are abolished in a novel strain of kappa-opioid receptor-1 knockout mice.
    Ansonoff MA; Zhang J; Czyzyk T; Rothman RB; Stewart J; Xu H; Zjwiony J; Siebert DJ; Yang F; Roth BL; Pintar JE
    J Pharmacol Exp Ther; 2006 Aug; 318(2):641-8. PubMed ID: 16672569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of direct and indirect dopamine agonists on the induction of gnawing in C57Bl/6J mice.
    Tirelli E; Witkin JM
    J Pharmacol Exp Ther; 1995 Apr; 273(1):7-15. PubMed ID: 7714815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.
    Chavkin C; Sud S; Jin W; Stewart J; Zjawiony JK; Siebert DJ; Toth BA; Hufeisen SJ; Roth BL
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1197-203. PubMed ID: 14718611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New neoclerodane diterpenoids isolated from the leaves of Salvia divinorum and their binding affinities for human kappa opioid receptors.
    Lee DY; Ma Z; Liu-Chen LY; Wang Y; Chen Y; Carlezon WA; Cohen B
    Bioorg Med Chem; 2005 Oct; 13(19):5635-9. PubMed ID: 16084728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Learning and memory impairment induced by salvinorin A, the principal ingredient of Salvia divinorum, in wistar rats.
    Braida D; Donzelli A; Martucci R; Capurro V; Sala M
    Int J Toxicol; 2011 Dec; 30(6):650-61. PubMed ID: 21960665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Salvinorin A and related diterpenes--biological activity and potential therapeutic uses].
    Piekielna J; Fichna J; Janecka A
    Postepy Biochem; 2012; 58(4):485-91. PubMed ID: 23662442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B; Katz JL; Alling K; Acri JB; Witkin JM
    J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology and anti-addiction effects of the novel κ opioid receptor agonist Mesyl Sal B, a potent and long-acting analogue of salvinorin A.
    Simonson B; Morani AS; Ewald AW; Walker L; Kumar N; Simpson D; Miller JH; Prisinzano TE; Kivell BM
    Br J Pharmacol; 2015 Jan; 172(2):515-31. PubMed ID: 24641310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unconditioned behavioral effects of the powerful kappa-opioid hallucinogen salvinorin A in nonhuman primates: fast onset and entry into cerebrospinal fluid.
    Butelman ER; Prisinzano TE; Deng H; Rus S; Kreek MJ
    J Pharmacol Exp Ther; 2009 Feb; 328(2):588-97. PubMed ID: 19001155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hallucinogen derived from Salvia divinorum, salvinorin A, has kappa-opioid agonist discriminative stimulus effects in rats.
    Willmore-Fordham CB; Krall DM; McCurdy CR; Kinder DH
    Neuropharmacology; 2007 Sep; 53(4):481-6. PubMed ID: 17681558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and chemical modification of clerodane diterpenoids from Salvia species as potential agonists at the kappa-opioid receptor.
    Li Y; Husbands SM; Mahon MF; Traynor JR; Rowan MG
    Chem Biodivers; 2007 Jul; 4(7):1586-93. PubMed ID: 17638340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.